PrintClick here to print
Go Back

June 2012
Turning toward Turkey
Code: E061205
June 2012
Australian pharma nabs U.S. shareholders
Code: E061206
June 2012
A duo that’s sweet on new biomarkers
Code: E061207
June 2012
A joint research project
Code: E061208
June 2012
Evotec licenses inflammatory disease compounds to Chinese pharma
June 2012
Sandoz acquires Fougera Pharmaceuticals
Code: E061203
June 2012
Zealand Pharma inks license agreement with Abbott
June 2012
Pluristem secures grant for R&D
June 2012
Nanobiotix, TJU partner on preclinical research program